… in vitro studies of 18 F-FDG uptake and mTOR inhibition in NSCLC cells. … 18 F-FDG uptake
in lung cancer. The results of the present study revealed that the amount of 18 F-FDG uptake …

… uptake of 18F-FDG in most lung cancers and the demonstration that successful treatment
reduces uptake have led to increasing enthusiasm for the use of PET … role of 18F-FDG PET are …

… 18 F-FDG PET for the assessment of chemotherapy response in patients with non–small cell
lung cancer. … Methods: In 51 patients, dynamic 18 F-FDG PET was performed before and at 5…

… -body 18 F-FDG PET on staging and managing patients with small cell lung cancer (SCLC). …
Whole-body 18 F-FDG PET was performed for initial staging in 24 patients and for restaging …

… various FDG PET/CT-derived parameters of lung cancer … 18 F-FDG PET/CT predicted a
higher risk of recurrence or death in surgical NSCLC patients. Our findings suggest that FDG PET/…

… Tumor 18 F-FDG uptake (SUV), pathologic stage, and lesion … the 18 F-FDG uptake in primary
NSCLC determined by PET … F-FDG uptake was superior to pathologic stage in predicting …

… of the value of 18 F-FDG PET for monitoring response to … to assess the actual value of 18
F-FDG PET as a response-… trial on the value of 18 F-FDG PET for monitoring response in …

… tumor PET-FDG uptake features associated with gene expression signatures and survival.
Fourteen quantitative PET imaging features describing FDG uptake … For each FDG uptake …

… (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in the thoracic lymph node staging of
non-small cell lung cancer (… (CT) and FDG-PET scanning were evaluated retrospectively. Thirty …

… PET and 18 F-FDG have the potential to follow the … cell lung cancer and to predict success
or failure of the therapy. Methods: We studied 16 patients with non–small cell lung cancer as …